Journal
GASTROENTEROLOGY
Volume 150, Issue 8, Pages 1769-1777Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2016.02.066
Keywords
Nonalcoholic Fatty Liver Disease; Lipotoxicity; Wound-Healing Response; Misrepair
Categories
Funding
- National Institutes of Health [DK0077794, DK053792, R37 AA010154]
- Duke Endowment: The Florence McAlister Professorship
- Fundacao para a Ciencia e Tecnologia, FCT, Portugal
Ask authors/readers for more resources
Nonalcoholic steatohepatitis (NASH) is a necroinflammatory response that ensues when hepatocytes are injured by lipids (lipotoxicity). NASH is a potential outcome of nonalcoholic fatty liver (NAFL), a condition that occurs when lipids accumulate in hepatocytes. NASH may be reversible, but it can also result in cirrhosis and primary liver cancer. We are beginning to learn about the mechanisms of progression of NAFL and NASH. NAFL does not inevitably lead to NASH because NAFL is a heterogeneous condition. This heterogeneity exists because different types of lipids with different cytotoxic potential accumulate in the NAFL, and individuals with NAFL differ in their ability to defend against lipotoxicity. There are no tests that reliably predict which patients with NAFL will develop lipotoxicity. However, NASH encompasses the spectrum of wound-healing responses induced by lipotoxic hepatocytes. Differences in these wound-healing responses among individuals determine whether lipotoxic livers regenerate, leading to stabilization or resolution of NASH, or develop progressive scarring, cirrhosis, and possibly liver cancer. We review concepts that are central to the pathogenesis of NASH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available